Bladder Cancer
Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder, leading to symptoms such as blood in urine, frequent urination, and pain during urination.
Bladder Cancer: Intravesical Gemcitabine Treatment
We are studying the effectiveness and safety of a drug called gemcitabine for patients with low-grade bladder cancer. This trial aims to see how well it works in treating this specific type of cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a female patient who is pregnant or breastfeeding?
- Are you currently using effective contraception if you are a female of childbearing potential?
- Do you have a history of bladder cancer that is low or intermediate risk?
- Do you have more than 5 tumors in your bladder?
- Is the largest tumor in your bladder larger than 15 mm?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Bendacitabin
Demozar
Gemci-Cell
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Vienna
Department of Urology
Vienna, Austria
Sponsor: Medical University Of Vienna
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.